Carpal tunnel syndrome is a medical condition of numbness, weakness, and tingling in the hand due to compression of the median nerve in the wrist. The median nerve is located on the palm side and also known as the carpal tunnel.
DelveInsight’s “Carpal Tunnel Syndrome Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Carpal Tunnel Syndrome, historical and forecasted epidemiology as well as the Carpal Tunnel Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights from the Carpal Tunnel Syndrome Market Report:
- According to the National Institute for Occupational Safety & Health (NIOSH), more than 230,000 procedures are performed for carpal tunnel surgery every year.
- Approximately 23% of people with carpal tunnel syndrome are able to resume their profession after the surgery.
- Usually, women are more affected by carpal tunnel syndrome than men.
- More than 8.3 million people are diagnosed with carpal tunnel syndrome every year.
- Increasing research and development activities, introduction of innovative therapies, rising demand for effective therapies among patients, and growing disease prevalence are projected to fuel the carpal tunnel syndrome treatment market in the near future.
View Report @ https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
Request for Sample Report @ https://www.delveinsight.com/sample-request/carpal-tunnel-syndrome-market
The most common signs and symptoms of carpal tunnel syndrome are tingling, numbness, pain in the thumb, pain and burning that travels up to the arm, weakness in the muscles of the hand, and the wrist pain at night that interferes with sleep. Health care specialists recommend nerve conduction studies, physical examination, and other tests to confirm the presence of carpal tunnel syndrome.
Some other frequent conditions associated with carpal tunnel syndrome are thyroid dysfunction, high blood pressure, diabetes, and autoimmune disorders such as rheumatoid arthritis.
View Report @ https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
Request for Sample Report @ https://www.delveinsight.com/sample-request/carpal-tunnel-syndrome-market
Some of the Carpal Tunnel Syndrome Companies:
- Pfizer, Inc
- ZARS Pharma Inc.
- Allergan
- GlaxoSmithKline
- Novartis AG
- Bristol-Myers Squibb and Company
- Wockhardt Ltd
- Teva Pharmaceutical
- Johnson & Johnson
- Mylan Pharmaceuticals
- Aurobindo Pharma Ltd.
- And Many More
View Report @ https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
Request for Sample Report @ https://www.delveinsight.com/sample-request/carpal-tunnel-syndrome-market
Carpal Tunnel Syndrome Pipeline Therapies:
- Synera
- Gabapentin
- Botulinum Toxin Type A
- And Many Others
Table of Contents
| 1. | Report Introduction |
| 2. | Executive Summary of Carpal Tunnel Syndrome |
| 3. | Carpal Tunnel Syndrome Market Overview at a Glance |
| 4. | Disease Background and Overview: Carpal Tunnel Syndrome |
| 5. | Case Reports of Carpal Tunnel Syndrome |
| 6. | Carpal Tunnel Syndrome Patient Journey |
| 7. | Carpal Tunnel Syndrome Epidemiology and Patient Population |
| 8. | Epidemiology of Carpal Tunnel Syndrome by Countries (2018–2030) |
| 9. | Carpal Tunnel Syndrome Treatments and Medical Practices |
| 10. | Carpal Tunnel Syndrome Marketed Therapies |
| 11. | Carpal Tunnel Syndrome Emerging Therapies |
| 12. | Carpal Tunnel Syndrome Market Size |
| 13. | 7MM: Country-wise Market Analysis |
| 14. | Carpal Tunnel Syndrome Market Drivers |
| 15. | Carpal Tunnel Syndrome Market Barriers |
| 16. | SWOT Analysis |
| 17. | KOL Views |
| 18. | Reimbursement and market access |
| 19. | Report Methodology |
| 20. | DelveInsight Capabilities |
| 21. | Disclaimer |
| 22. | About DelveInsight |
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.